SCHEMBL20188172

SCHEMBL20188172

CCCOC(=O)[C@H](C)NC(N)=O

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CAD P27708 1/20 0.40
TSHR P16473 3/20 0.39
METAP2 P50579 8/20 0.38
METAP1 P53582 6/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
BIRC2 Q13490 1/20 0.36
RAB9A P51151 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
MAPT P10636 1/20 0.35
LMNA P02545 1/20 0.35
CYP3A4 P08684 1/20 0.35
NFKB1 P19838 1/20 0.35
ADRA1A P35348 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HCAR2 Q8TDS4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28804446 0.85 EPHX1 (0.49) TSHR
SCHEMBL27654640 0.83 CAD (0.55) CADTSHRMETAP2METAP1ALDH1A1
SCHEMBL5813322 0.82 GAA (0.43) TSHRMETAP2METAP1ALDH1A1NPSR1
SCHEMBL5813330 0.82 GAA (0.43) TSHRMETAP2METAP1ALDH1A1NPSR1
SCHEMBL27286440 0.82 CAD (0.41) CADTSHRALDH1A1MAPK1SMN1; SMN2
SCHEMBL20187916 0.81 TSHR (0.37) CADTSHRMETAP2METAP1ALDH1A1
SCHEMBL28544834 0.78 HCAR2 (0.37) TSHRMETAP2METAP1ALDH1A1MAPK1
SCHEMBL15043976 0.78 CA14 (0.50) CADTSHRALDH1A1MAPK1SMN1; SMN2
SCHEMBL22822298 0.78 CA14 (0.50) CADTSHRALDH1A1MAPK1SMN1; SMN2
SCHEMBL10055358 0.78 CA14 (0.50) CADTSHRALDH1A1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3544635-A2 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES Mersana Therapeutics, Inc. (US) 2019-10-02 EP disclosed
WO-2018098269-A2 PEPTIDE-CONTAINING LINKERS FOR ANTIBODY-DRUG CONJUGATES MERSANA THERAPEUTICS, INC. (US) 2018-05-31 WO disclosed